+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oral Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Oral Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Oral Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 185 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5952857
Free Webex Call
10% Free customization
Description Jump to:

Tablets is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Oral Drug Delivery Market, valued at USD 129.77 Billion in 2024, is projected to experience a CAGR of 7.80% to reach USD 203.65 Billion by 2030. The Global Oral Drug Delivery Market encompasses the segment of the pharmaceutical industry dedicated to developing, manufacturing, and commercializing therapeutic agents administered via the oral route. This method is highly favored due to its inherent patient convenience, ease of administration, and potential for improved compliance compared to other delivery methods. Key drivers propelling this market include the increasing global prevalence of chronic diseases such as cardiovascular conditions, diabetes, and cancer, which necessitate long-term medication regimens.

Key Market Drivers

Technological advancements in drug delivery systems and expanded investment in pharmaceutical research and development exert considerable influence on the Global Oral Drug Delivery Market. Innovations in solubility enhancement, controlled release mechanisms, and targeted delivery are broadening the range of orally administered therapies, including complex molecules once limited to injectable routes. These developments improve drug stability, bioavailability, and therapeutic precision. For instance, according to Fierce Biotech, in April 2025, Roche acquired Carmot Therapeutics for $2.7 billion in late 2023, securing access to three GLP-1 receptor agonists with potential for treating obesity, including oral administration. Such strategic investments emphasize the industry's dedication to patient-friendly oral formulations.

Key Market Challenges

A significant challenge impeding market expansion for oral drug delivery is the stringent regulatory approval processes. These complex procedures inherently increase the time and financial investment required to bring new oral formulations to market. This extended development timeline and heightened cost create substantial barriers for pharmaceutical companies, particularly those developing innovative therapies, by prolonging the period before potential revenue generation.

Key Market Trends

The development of personalized oral therapies is a significant trend reshaping the Global Oral Drug Delivery Market by moving towards treatments tailored to individual patient profiles. This approach leverages advancements in diagnostics and genomics to customize drug selection, dosage, and formulation, enhancing therapeutic efficacy and minimizing adverse effects. According to the Personalized Medicine Coalition (PMC), in 2024, the FDA approved 18 new personalized medicines, representing approximately 38 percent of all newly approved therapeutic molecular entities. These approvals underscore a growing industry commitment to individualized treatment pathways.

Key Market Players Profiled:

  • Novartis AG
  • Biocon Ltd.
  • NovoNordisk A/S
  • F.Hoffmann-La Roche Ltd.
  • Bayer AG
  • Emishphere Technologies Inc.
  • Enteris Biopharma Inc.
  • Merrion Pharmaceuticals Plc.
  • Amgen Inc.
  • Pfizer Inc.

Report Scope:

In this report, the Global Oral Drug Delivery Market has been segmented into the following categories:

By Formulation:

  • Tablets
  • Capsules
  • Drops
  • Liquid or Syrup

By Type:

  • Controlled Release
  • Orodispersible Tablets
  • Others

By Therapy Area:

  • Oncology
  • Musculoskeletal
  • Immunology
  • Gastrointestinal
  • Respiratory
  • Cardiovascular
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Centres
  • Diagnostic Centres
  • Clinics
  • Others

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oral Drug Delivery Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Oral Drug Delivery Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Formulation (Tablets, Capsules, Drops, Liquid or Syrup)
5.2.2. By Type (Controlled Release, Orodispersible Tablets, Others)
5.2.3. By Therapy Area (Oncology, Musculoskeletal, Immunology, Gastrointestinal, Respiratory, Cardiovascular, Others)
5.2.4. By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Clinics, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Oral Drug Delivery Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Formulation
6.2.2. By Type
6.2.3. By Therapy Area
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Oral Drug Delivery Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Formulation
6.3.1.2.2. By Type
6.3.1.2.3. By Therapy Area
6.3.1.2.4. By End User
6.3.2. Canada Oral Drug Delivery Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Formulation
6.3.2.2.2. By Type
6.3.2.2.3. By Therapy Area
6.3.2.2.4. By End User
6.3.3. Mexico Oral Drug Delivery Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Formulation
6.3.3.2.2. By Type
6.3.3.2.3. By Therapy Area
6.3.3.2.4. By End User
7. Europe Oral Drug Delivery Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Formulation
7.2.2. By Type
7.2.3. By Therapy Area
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Oral Drug Delivery Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Formulation
7.3.1.2.2. By Type
7.3.1.2.3. By Therapy Area
7.3.1.2.4. By End User
7.3.2. France Oral Drug Delivery Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Formulation
7.3.2.2.2. By Type
7.3.2.2.3. By Therapy Area
7.3.2.2.4. By End User
7.3.3. United Kingdom Oral Drug Delivery Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Formulation
7.3.3.2.2. By Type
7.3.3.2.3. By Therapy Area
7.3.3.2.4. By End User
7.3.4. Italy Oral Drug Delivery Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Formulation
7.3.4.2.2. By Type
7.3.4.2.3. By Therapy Area
7.3.4.2.4. By End User
7.3.5. Spain Oral Drug Delivery Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Formulation
7.3.5.2.2. By Type
7.3.5.2.3. By Therapy Area
7.3.5.2.4. By End User
8. Asia-Pacific Oral Drug Delivery Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Formulation
8.2.2. By Type
8.2.3. By Therapy Area
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Oral Drug Delivery Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Formulation
8.3.1.2.2. By Type
8.3.1.2.3. By Therapy Area
8.3.1.2.4. By End User
8.3.2. India Oral Drug Delivery Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Formulation
8.3.2.2.2. By Type
8.3.2.2.3. By Therapy Area
8.3.2.2.4. By End User
8.3.3. Japan Oral Drug Delivery Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Formulation
8.3.3.2.2. By Type
8.3.3.2.3. By Therapy Area
8.3.3.2.4. By End User
8.3.4. South Korea Oral Drug Delivery Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Formulation
8.3.4.2.2. By Type
8.3.4.2.3. By Therapy Area
8.3.4.2.4. By End User
8.3.5. Australia Oral Drug Delivery Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Formulation
8.3.5.2.2. By Type
8.3.5.2.3. By Therapy Area
8.3.5.2.4. By End User
9. Middle East & Africa Oral Drug Delivery Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Formulation
9.2.2. By Type
9.2.3. By Therapy Area
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Oral Drug Delivery Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Formulation
9.3.1.2.2. By Type
9.3.1.2.3. By Therapy Area
9.3.1.2.4. By End User
9.3.2. UAE Oral Drug Delivery Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Formulation
9.3.2.2.2. By Type
9.3.2.2.3. By Therapy Area
9.3.2.2.4. By End User
9.3.3. South Africa Oral Drug Delivery Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Formulation
9.3.3.2.2. By Type
9.3.3.2.3. By Therapy Area
9.3.3.2.4. By End User
10. South America Oral Drug Delivery Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Formulation
10.2.2. By Type
10.2.3. By Therapy Area
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Oral Drug Delivery Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Formulation
10.3.1.2.2. By Type
10.3.1.2.3. By Therapy Area
10.3.1.2.4. By End User
10.3.2. Colombia Oral Drug Delivery Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Formulation
10.3.2.2.2. By Type
10.3.2.2.3. By Therapy Area
10.3.2.2.4. By End User
10.3.3. Argentina Oral Drug Delivery Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Formulation
10.3.3.2.2. By Type
10.3.3.2.3. By Therapy Area
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Oral Drug Delivery Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Novartis AG
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Biocon Ltd.
15.3. NovoNordisk A/S
15.4. F.Hoffmann-La Roche Ltd.
15.5. Bayer AG
15.6. Emishphere Technologies Inc.
15.7. Enteris Biopharma Inc.
15.8. Merrion Pharmaceuticals Plc.
15.9. Amgen Inc.
15.10. Pfizer Inc.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Oral Drug Delivery market report include:
  • Novartis AG
  • Biocon Ltd.
  • NovoNordisk A/S
  • F.Hoffmann-La Roche Ltd.
  • Bayer AG
  • Emishphere Technologies Inc.
  • Enteris Biopharma Inc.
  • Merrion Pharmaceuticals Plc.
  • Amgen Inc.
  • Pfizer Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 129.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 203.65 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Oral Drug Delivery Market - Global Strategic Business Report - Product Image

Oral Drug Delivery Market - Global Strategic Business Report

  • Report
  • 498 Pages
  • Global
From
Oral Drug Delivery Market - Forecasts from 2025 to 2030 - Product Image

Oral Drug Delivery Market - Forecasts from 2025 to 2030

  • Report
  • 151 Pages
  • Global
From
Oral Macromolecular Formulation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Oral Macromolecular Formulation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 195 Pages
  • Global
From
Oral Thin Films Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Oral Thin Films Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Long-Acting Drug Delivery Technologies and Services Market Report and Forecast 2025-2034 - Product Image

Long-Acting Drug Delivery Technologies and Services Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.